Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 48% ± 12% | |
lung | 17 studies | 54% ± 18% | |
intestine | 12 studies | 53% ± 25% | |
kidney | 9 studies | 60% ± 14% | |
eye | 9 studies | 42% ± 19% | |
brain | 9 studies | 33% ± 9% | |
lymph node | 6 studies | 50% ± 22% | |
liver | 6 studies | 51% ± 19% | |
bone marrow | 5 studies | 44% ± 15% | |
pancreas | 4 studies | 60% ± 24% | |
placenta | 4 studies | 64% ± 22% | |
heart | 4 studies | 31% ± 13% | |
uterus | 4 studies | 61% ± 16% | |
prostate | 4 studies | 41% ± 13% | |
breast | 4 studies | 49% ± 7% | |
ovary | 3 studies | 25% ± 7% | |
adrenal gland | 3 studies | 49% ± 3% | |
esophagus | 3 studies | 62% ± 26% | |
skin | 3 studies | 36% ± 13% | |
thymus | 3 studies | 68% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 8312.89 | 359 / 359 | 100% | 175.44 | 286 / 286 |
skin | 100% | 7329.74 | 1808 / 1809 | 100% | 171.78 | 472 / 472 |
esophagus | 100% | 8266.42 | 1444 / 1445 | 100% | 128.22 | 183 / 183 |
ovary | 100% | 3991.69 | 180 / 180 | 100% | 181.16 | 429 / 430 |
intestine | 100% | 10934.95 | 966 / 966 | 100% | 206.38 | 525 / 527 |
bladder | 100% | 5907.86 | 21 / 21 | 100% | 169.29 | 502 / 504 |
uterus | 100% | 4717.12 | 170 / 170 | 100% | 167.14 | 457 / 459 |
liver | 100% | 8399.89 | 225 / 226 | 100% | 160.75 | 406 / 406 |
thymus | 100% | 6077.34 | 651 / 653 | 100% | 129.74 | 604 / 605 |
kidney | 100% | 14894.81 | 89 / 89 | 99% | 160.76 | 895 / 901 |
breast | 100% | 6581.54 | 459 / 459 | 99% | 132.19 | 1108 / 1118 |
lung | 99% | 5098.46 | 573 / 578 | 100% | 151.13 | 1152 / 1155 |
adrenal gland | 100% | 7714.45 | 258 / 258 | 99% | 131.80 | 227 / 230 |
prostate | 100% | 4937.51 | 244 / 245 | 99% | 120.64 | 497 / 502 |
brain | 99% | 7027.27 | 2609 / 2642 | 99% | 109.59 | 697 / 705 |
pancreas | 92% | 2563.43 | 302 / 328 | 99% | 112.85 | 177 / 178 |
adipose | 100% | 7208.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 146.23 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 199.40 | 29 / 29 |
spleen | 100% | 5218.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 170.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 90.37 | 1 / 1 |
muscle | 100% | 14353.44 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 4866.82 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 25265.03 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 5923.41 | 720 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0000276 | Cellular component | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0015078 | Molecular function | proton transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
Gene name | ATP5MC3 |
Protein name | ATP synthase lipid-binding protein (ATPase protein 9) (ATPase subunit c) ATP synthase F(0) complex subunit C3, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 3) (ATP synthase proteolipid P3) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C3) (ATPase protein 9) (ATPase subunit c) |
Synonyms | ATP5G3 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. A homomeric c-ring of probably 10 subunits is part of the complex rotary element. FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. A homomeric c-ring of probably 10 subunits is part of the complex rotary element. . |
Accessions | ENST00000284727.9 ENST00000409194.5 P48201 ENST00000392541.3 Q6LEU9 |